No abstract

Purpose. To compare the visual function and patient satisfaction in patients after implantation of the AcrySof ReSTOR SN6AD1 multifocal intraocular lens (IOL) and after implantation of the AcrySof SA60AТ spherical monofocal IOL and Akreos АО aspheric monofocal IOL in cataract surgery.Materials. 34 patients had SN6AD1 multifocal (group 1, 48 eyes), 19 patients had Akreos АО monofocal aspheric (group 2, 30 eyes) and 13 patients had AcrySof SA60AТ monofocal spherical (group 3, 18 eyes) IOL implantations. Patients with multifocal IOL were closely paired in age, sex, and ocular findings with patients who had monofocal IOL implantation. Six months postoperatively uncorrected/corrected distance visual acuity (UDVA/CDVA), uncorrected intermediate (60 cm) and near (35 cm) visual acuity (UNVA), the defocus curve, contrast sensitivity and a quality-of-life questionnaire were evaluated. Furthermore, independence from glasses and the presence of optical phenomena were assessed.Results. Patients in group 2 had statistically better UDVA than in group 1 (p = 0,037). There was no significant difference in the mean uncorrected intermediate and best corrected distance visual acuities between the groups. UNVA was better in group 1 than in groups 2, 3 (p < 0,0001). Photopic contrast sensitivity for high spatial frequencies was better for the groups 2 and 3. Glare was reported by 5,9% in the multifocal group. Halos occurred in 32,4% of patients in group 1. No one reported unwanted visual symptoms in monofocal groups.Conclusion. Multifocal IOLs provided higher spectacle independence and satisfactory functional vision over a broad range of distances but were associated with increased subjective visual symptoms, reduced photopic contrast sensitivity for high spatial frequencies and distance visual quality compared with the monofocal IOLs.

G Факоэмульсификация (ФЭ) на сегодняшний день представляет собой основную методику хирургиче-ского лечения катаракты, которая обеспечивает раннюю клинико-функциональную реабилитацию па-циентов. Послеоперационный отёк роговицы является частой и нежелательной клинической ситуацией. Целью клинического исследования стало изучение терапевтического эффекта гипертонического раство-ра (3 %) хлорида натрия «Окусалин» на отёк роговицы в раннем послеоперационном периоде. материалы и методы. В исследование включено 60 пациентов (65 глаз) с послеоперационным отёком ро-говицы. Основную группу составили 35 глаз, контрольную -30 глаз. Пациенты первой группы в после-операционном периоде дополнительно использовали 3 % гипертонические глазные капли хлорида натрия («Окусалин»), пациенты второй группы получали стандартную схему лечения. У всех пациентов до и после операции (через 1, 7 дней и 1 месяц) оценивали субъективные и объективные (остроту зрения, толщину ро-говицы в центральном отделе и в зоне туннельного разреза) показатели функционального состояния глаз. Результаты исследования продемонстрировали, что применение 3 % раствора хлорида натрия способ-ствует улучшению остроты зрения за счёт уменьшения толщины роговицы в центральном отделе уже к 7-му дню после операции. Использование «Окусалина» в раннем послеоперационном периоде позволяет сократить сроки клинико-функциональной реабилитации пациентов и уменьшить субъективные жалобы.G ключевые слова: факоэмульсификация; отёк роговицы; гипертонический раствор; пахиметрия. G Currently phacoemulsification (PE) is the main technique of cataract surgery, which provides for patients early clinical and functional rehabilitation. Post-operative corneal edema is a frequent and undesirable clinical situation. The purpose of the study was to evaluate clinical efficacy of 3% sodium chloride ("Ocusaline") treatment in patients with corneal edema in the early post-operative period. Materials and methods. 60 patients (65 eyes) with post-operative corneal edema were included in the study. The main group consisted of 35 eyes; 30 eyes were included into the control group. Patients in the group 1 in addition to the routine post-operative treatment were treated with 3% sodium chloride hypertonic eye drops ("Ocusaline"); and patients in group 2 were treated according to the standard protocol. In all patients before and after surgery (in 1 day, 7 days and 1 month), subjective and objective indices of functional ophthalmic state (visual acuity, pachymetry in the central area and in the tunnel incision zone) were estimated. Results. The study results demonstrated that 3% sodium chloride hypertonic solution use facilitates visual acuity improvement due to the decrease of corneal thickness in the central area already at one week after surgery. The use of "Ocusaline" in the early post-operative period allows to decrease clinical and functional rehabilitation terms and to reduce subjective complaints of patients.

Purpose. To assess the efficacy and safety of implanting a supplementary toric intraocular lens (IOL) in the ciliary sulcus in one eye and a toric IOL in the fellow eye in highly hyperopic patients with concomitant astigmatism. Methods. This study included highly hyperopic patients (axial length 21.3-22.0 mm) with concomitant regular corneal astigmatism. The group consist of 6 patients aged from 40 to 76 years. Supplementary IOL (Sulcoflex Toric 653T, Rayner) was implanted in the ciliary sulcus in the pseudophakic eye 1 month after previous phacoemulsification surgery. A toric IOL (AcrySof IQ Toric, Alcon) was implanted in the fellow eye. Postoperative follow-up visits were performed at 1 week, 1 month and 6 months. Results. Postoperatively, in all patients UDVA (uncorrected distance visual acuity) improved and remained stable throughout the follow-up period. Lower visual acuity in the eyes with toric IOLs is associated with errors in IOL calculation, occurring often in “short eyes”. Conclusion. Using different IOL types for astigmatism correction in highly hyperopic patients is justified and can give good visual results. A “short eye” is not a contraindication for supplementary IOL implantation, but it is necessary to perform laser iridotomy to minimize the risk of pupillary block.